Expression levels of CXCR4 in CD5+ were similar to that in CD5−ABC-DLBCL (P = .59), although significantly higher than in CD5− patients with GCB-DLBCL (P = .028, Figure 1L). This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.